• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    TG Therapeutics, Inc. - Common Stock (NQ:TGTX)

    41.97 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, May 6, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 540
    Open 41.97
    Bid (Size) 39.14 (200)
    Ask (Size) 42.00 (1,200)
    Prev. Close 41.97
    Today's Range 41.97 - 41.97
    52wk Range 25.28 - 42.09
    Shares Outstanding 154,420,772
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    TG Therapeutics (TGTX) Q1 2026 Earnings Transcript ↗
    TG Therapeutics (TGTX) Q1 2026 Earnings Transcript 
    Via The Motley Fool
    News headline image
    TGTX Q1 2025 Earnings Call Transcript ↗
    TGTX Q1 2025 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings

    Performance

    YTD
    +43.3%
    +43.3%
    1 Month
    +24.6%
    +24.6%
    3 Month
    +44.1%
    +44.1%
    6 Month
    +23.3%
    +23.3%
    1 Year
    +20.4%
    +20.4%

    More News

    Read More
    TG Therapeutics (NASDAQ:TGTX) Q1 2026 Earnings Beat Revenue Guidance but Miss EPS Estimates ↗
    Via Chartmill
    Topics Earnings
    TG Therapeutics Inc (NASDAQ:TGTX) Shows Strong Growth and Technical Setup for Potential Upside ↗
    Via Chartmill
    TG Therapeutics Inc (NASDAQ:TGTX): An Affordable Growth Stock with Strong Momentum ↗
    Via Chartmill
    TG Therapeutics Inc (NASDAQ:TGTX) Presents a Compelling Momentum Case with Strong Growth and Technical Setup ↗
    Via Chartmill
    TG THERAPEUTICS INC (NASDAQ:TGTX) Q4 2025 Earnings Miss Estimates Despite Strong BRIUMVI Outlook ↗
    Via Chartmill
    Topics Earnings
    TG Therapeutics Stock Pops As Briumvi Boom Reignites Bull Case: Goldman Sachs Sees Room For 32% Rally ↗
    Via Stocktwits
    News headline image
    What to Know About This Obesity Drug Developer That Just Drew a New $7 Million Investment ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Biotech With a Breakout MS Drug Draws $8 Million Investment Amid 30% Stock Drop ↗
    Via The Motley Fool
    News headline image
    TG Therapeutics (TGTX) Q4 2025 Earnings Transcript ↗
    Via The Motley Fool
    TG Therapeutics Stock Soars After Company Ups Guidance For Multiple Sclerosis Drug ↗
    Via Stocktwits
    News headline image
    Soleus Adds a Significant Number of Celcuity Shares ↗
    Via The Motley Fool
    News headline image
    TG Therapeutics Lights Up Super Bowl With Christina Applegate MS Campaign — Retail Sees 'Huge Win' ↗
    Via Stocktwits
    News headline image
    Hussman Strategic Advisors Sells 126,000 TG Therapeutics Shares ↗
    Via The Motley Fool
    News headline image
    Retail Traders Are Piling Into TG Therapeutics – What’s Driving The Chatter? ↗
    Via Stocktwits
    Topics Artificial Intelligence
    News headline image
    TGTX Rallies 7% After Hours On Revenue Estimates Based On Strong Briumvi Demand Through 2026 ↗
    Via Stocktwits
    Topics Artificial Intelligence
    These stocks are moving in today's after hours session ↗
    Via Chartmill
    News headline image
    TG Therapeutics TGTX Q3 2025 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    10 Health Care Stocks With Whale Alerts In Today's Session ↗
    Via Benzinga
    News headline image
    TG Therapeutics Crumbles After Roche Unveils Its 'Unprecedented' Test Results ↗
    Via Investor's Business Daily
    News headline image
    Hussman Sells Off All 21,000 CHKP Shares Valued At $4.65 Million ↗
    Via The Motley Fool
    News headline image
    10 Health Care Stocks Whale Activity In Today's Session ↗
    Via Benzinga
    News headline image
    Highly Watched TG Therapeutics Smashes Profit Views — With A Caveat ↗
    Via Investor's Business Daily
    Topics Earnings
    News headline image
    Top Stocks With Earnings This Week: Joby, IonQ, AMD and More ↗
    Via Benzinga

    Frequently Asked Questions

    Is TG Therapeutics, Inc. - Common Stock publicly traded?
    Yes, TG Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does TG Therapeutics, Inc. - Common Stock trade on?
    TG Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for TG Therapeutics, Inc. - Common Stock?
    The ticker symbol for TG Therapeutics, Inc. - Common Stock is TGTX on the Nasdaq Stock Market
    What is the current price of TG Therapeutics, Inc. - Common Stock?
    The current price of TG Therapeutics, Inc. - Common Stock is 41.97
    When was TG Therapeutics, Inc. - Common Stock last traded?
    The last trade of TG Therapeutics, Inc. - Common Stock was at 05/06/26 04:00 PM ET
    What is the market capitalization of TG Therapeutics, Inc. - Common Stock?
    The market capitalization of TG Therapeutics, Inc. - Common Stock is 6.48B
    How many shares of TG Therapeutics, Inc. - Common Stock are outstanding?
    TG Therapeutics, Inc. - Common Stock has 6B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.